Article List

WPRIM Management System> DCMS> Clinical and Molecular Hepatology> 2015> 21> 4

1. Erectile dysfunction in patients with liver disease related to chronic hepatitis B.	Page:352—357
2. What we know about paracentesis induced circulatory dysfunction?.	Page:349—351
3. Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future.	Page:344—348
4. Imaging findings of mimickers of hepatocellular carcinoma.	Page:326—343
5. Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase.	Page:319—325
6. Focal type of peliosis hepatis.	Page:398—401
7. Intrahepatic bile duct adenoma in a patient with chronic hepatitis B accompanied by elevation of alpha-fetoprotein.	Page:393—397
8. Peliosis hepatis presenting with massive hepatomegaly in a patient with idiopathic thrombocytopenic purpura.	Page:387—392
9. Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study.	Page:379—386
10. Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study.	Page:372—378
11. The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction.	Page:365—371
12. Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in Korea.	Page:358—364